Learn how personalized cancer vaccines work and what to watch for at ESMO 2026. A vaccine made from a person’s own tumor has become the first of its kind to succeed in a phase 3 trial. Full results ...

Scancell Holdings PLC (AIM:SCLP, OTC:SCNLF, FRA:SCP), the developer of cancer immunotherapies, is pressing ahead with plans ...

Trials investigating mRNA vaccines for lung cancer, pancreatic cancer and other diseases are already underway.

New details have emerged about an initiative that starts in December to fast-track the vaccines, similar to the successful ...

MRNA, BNTX and NVAX shares rally after reports of a planned NIH-backed initiative to accelerate personalized cancer vaccines ...

Laura Ferris urges risk-based melanoma screening and highlights earlier immunotherapy, selective imaging, vaccine limits and ...

A carefully designed clinical trial that set out to supercharge the immune system’s attack on advanced melanoma has delivered ...

Investors Should Know: Personalized mRNA cancer vaccines are moving beyond their first major clinical success in melanoma ...

Researchers are testing a vaccine approach that may change future cancer treatment.

Moderna stock has surged nearly 600% this year on a cancer vaccine trial result that almost no one outside the trial has ...

The recent success of a late-stage mRNA cancer vaccine, showing the drug stopped the return of melanoma, has boosted hopes ...